Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Vanassche

Showing results (31-40 of 145) with videos related to

Pageof 15
Sort By:
International Journal of Stroke : Official Journal of the International Stroke Society|May 19, 2015
Global survey of the diagnostic evaluation and management of cryptogenic ischemic strokeMohana Giruparajah, Jackie Bosch, Thomas Vanassche, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|September 22, 2025
Epidemiology of Venous Thromboembolism in Belgium: A Cohort StudyAndreas Verstraete, Nicholas Cauwenberghs, Shayan Calhori, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 12, 2023
Predictive Factors and Clinical Events Associated with Edoxaban Interruption and Heparin Bridging Strategy: EMIT-AF/VTEAmparo Santamaria, Cathy Chen, Paolo Colonna, et al.
Haematologica|July 16, 2026
Short-term emicizumab in patients with acquired hemophilia AMargot Erard, Cedric Hermans, Thomas Vanassche, et al.
Cardiology in Review|June 15, 2012
Antithrombotic therapy in patients with heart valve prosthesesHadewich Hermans, Thomas Vanassche, Paul Herijgers, et al.
A&A Practice|August 14, 2020
Münchhausen Syndrome: A Case Report of an Unusual Cause of Vitamin K Antagonist IntoxicationLaurence Carlier, Steffen Rex, Thomas Vanassche, et al.
Thrombosis Research|August 15, 2015
Abnormal uterine bleeding in VTE patients treated with rivaroxaban compared to vitamin K antagonistsNico De Crem, Kathelijne Peerlinck, Thomas Vanassche, et al.
Clinical Oral Investigations|August 30, 2018
Local haemostatic measures after tooth removal in patients on antithrombotic therapy: a systematic reviewAnna Ockerman, Isabel Miclotte, Maarten Vanhaverbeke, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 22, 2020
Apixaban in patients on haemodialysis: a single-dose pharmacokinetics studyInes Van den Bosch, Thomas Bouillon, Peter Verhamme, et al.
Journal of Thrombosis and Haemostasis : JTH|March 8, 2025
Discrepancy between parallel anti-Xa and activated partial thromboplastin time is related to mortality in patients with Impella-supported cardiogenic shockCharlotte J Van Edom, Francesca Fiorelli, Tim Balthazar, et al.
Pageof 15

Showing results (31-40 of 145) with videos related to

Sort By:
Pageof 15
International Journal of Stroke : Official Journal of the International Stroke Society|May 19, 2015
Global survey of the diagnostic evaluation and management of cryptogenic ischemic strokeMohana Giruparajah, Jackie Bosch, Thomas Vanassche, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|September 22, 2025
Epidemiology of Venous Thromboembolism in Belgium: A Cohort StudyAndreas Verstraete, Nicholas Cauwenberghs, Shayan Calhori, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 12, 2023
Predictive Factors and Clinical Events Associated with Edoxaban Interruption and Heparin Bridging Strategy: EMIT-AF/VTEAmparo Santamaria, Cathy Chen, Paolo Colonna, et al.
Haematologica|July 16, 2026
Short-term emicizumab in patients with acquired hemophilia AMargot Erard, Cedric Hermans, Thomas Vanassche, et al.
Cardiology in Review|June 15, 2012
Antithrombotic therapy in patients with heart valve prosthesesHadewich Hermans, Thomas Vanassche, Paul Herijgers, et al.
A&A Practice|August 14, 2020
Münchhausen Syndrome: A Case Report of an Unusual Cause of Vitamin K Antagonist IntoxicationLaurence Carlier, Steffen Rex, Thomas Vanassche, et al.
Thrombosis Research|August 15, 2015
Abnormal uterine bleeding in VTE patients treated with rivaroxaban compared to vitamin K antagonistsNico De Crem, Kathelijne Peerlinck, Thomas Vanassche, et al.
Clinical Oral Investigations|August 30, 2018
Local haemostatic measures after tooth removal in patients on antithrombotic therapy: a systematic reviewAnna Ockerman, Isabel Miclotte, Maarten Vanhaverbeke, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 22, 2020
Apixaban in patients on haemodialysis: a single-dose pharmacokinetics studyInes Van den Bosch, Thomas Bouillon, Peter Verhamme, et al.
Journal of Thrombosis and Haemostasis : JTH|March 8, 2025
Discrepancy between parallel anti-Xa and activated partial thromboplastin time is related to mortality in patients with Impella-supported cardiogenic shockCharlotte J Van Edom, Francesca Fiorelli, Tim Balthazar, et al.
Pageof 15